Abbott’s Depakote Off-Label Settlement With DoJ Includes Court Probation

In a new twist, Abbott’s CEO and board must certify company’s compliance program with the court’s probation office. The requirements of the $1.5 billion settlement will transfer to Abbvie, the pharma company spinning out of Abbott.